Status:
ACTIVE_NOT_RECRUITING
Roadmap to Parenthood: Testing the Efficacy of a Decision Aid and Planning Tool for Family Building After Cancer
Lead Sponsor:
Stanford University
Collaborating Sponsors:
National Institutes of Health (NIH)
National Cancer Institute (NCI)
Conditions:
Quality of Life
Parenthood Status
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
This study will test a decision support intervention that consists of a web-based 'decision aid and planning tool' for family building after cancer in a randomized controlled trial.
Eligibility Criteria
Inclusion
- Assigned female at birth
- Aged 18 to 45 years old
- Understands verbal and written English
- History of a cancer diagnosis.
- Completed cancer treatment(s) with known or uncertain gonadotoxic effects (e.g., systemic chemotherapy, surgery or radiation affecting reproductive organs or hormone regulation, stem cell or bone marrow transplant, and/or immunotherapy)
- Interested in having a future child (or more children) or uncertain about family building plans
- Access to the Internet and use of a computer, tablet, or smartphone
- Ability to understand and the willingness to personally sign the written IRB-approved informed consent document
Exclusion
- Currently undergoing cancer treatment excluding long term adjuvant or maintenance therapies, such as tamoxifen
- Significant physical or mental disability that prevents completion of study activities
Key Trial Info
Start Date :
May 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2027
Estimated Enrollment :
256 Patients enrolled
Trial Details
Trial ID
NCT06050135
Start Date
May 20 2024
End Date
January 1 2027
Last Update
December 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Universtiy
Palo Alto, California, United States, 94305